Billiontoone Is A Precision Diagnostics Company Based In Menlo Park, California, Founded In 2016. With A Team Of Around 300 Employees, The Company Aims To Enhance Molecular Diagnostics By Making Them More Accurate, Efficient, And Accessible. Their Proprietary Technology, Quantitative Counting Templates (qcts), Allows For The Detection And Measurement Of Disease-related DNA Fragments At Single Base-pair Resolution, Significantly Improving Prenatal Screening And Liquid Biopsy Applications. The Company's Flagship Product, UNITY Screen, Is A Noninvasive Prenatal Test That Analyzes Fetal Cell-free DNA From A Maternal Blood Sample, Assessing Risks For Various Genetic Conditions And Chromosomal Aneuploidies. Billiontoone Also Offers UNITY Complete, Which Combines Multiple Screening Options Into One Test. In Oncology, They Provide Liquid Biopsy Tests Like Northstar Select And Northstar Response To Help Determine Cancer Treatment And Monitor Therapy Effectiveness. Additionally, They Have Developed A Covid-19 Test, Showcasing Their Technology's Versatility. Billiontoone Serves Pregnant Patients, Oncology Patients, And Clinical Research Organizations, And Has Experienced Significant Growth And Recognition In The Diagnostics Field.